GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integer Holdings Corp (NYSE:ITGR) » Definitions » Net Margin %
中文

Integer Holdings (Integer Holdings) Net Margin %

: 6.38% (As of Dec. 2023)
View and export this data going back to 2000. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Integer Holdings's Net Income for the three months ended in Dec. 2023 was $26 Mil. Integer Holdings's Revenue for the three months ended in Dec. 2023 was $413 Mil. Therefore, Integer Holdings's net margin for the quarter that ended in Dec. 2023 was 6.38%.

The historical rank and industry rank for Integer Holdings's Net Margin % or its related term are showing as below:

ITGR' s Net Margin % Range Over the Past 10 Years
Min: -0.95   Med: 6.54   Max: 13.82
Current: 5.68


ITGR's Net Margin % is ranked better than
62.99% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 0.045 vs ITGR: 5.68

Integer Holdings Net Margin % Historical Data

The historical data trend for Integer Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integer Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.66 7.20 7.93 4.82 5.68

Integer Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.86 3.45 5.99 6.74 6.38

Competitive Comparison

For the Medical Devices subindustry, Integer Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integer Holdings Net Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Integer Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Integer Holdings's Net Margin % falls into.



Integer Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Integer Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=90.65/1596.673
=5.68 %

Integer Holdings's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=26.357/413.151
=6.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integer Holdings  (NYSE:ITGR) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Integer Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Integer Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Integer Holdings (Integer Holdings) Business Description

Traded in Other Exchanges
Address
5830 Granite Parkway, Suite 1150, Plano, TX, USA, 75024
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.
Executives
Donald J Spence director C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304
Jean M. Hobby director 10000 WEHRLE DRIVE, CLARENCE NY 14031
Jim Stephens officer: President, CRM & Neuro 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Diron Smith officer: VP, Interim CFO 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph W Dziedzic director 1801 BAYBERRY COURT, RICHMOND VA 23226
Pamela G Bailey director 1200 G ST NW, STE 400, WASHINGTON DC 20005-3814
Jennifer M Bolt officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Carter Houghton officer: President, Electrochem 10000 WEHRLE DRIVE, CLARENCE NY 14031
Andrew Senn officer: SVP, Strategy and Business Dev 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Marshall Mcalister C Ii officer: SVP, Gen Counsel & Secretary 1801 BAYBERRY COURT, P.O. BOX 18100, RICHMOND VA 23226
Margaret Carthy officer: SVP, Quality & Regulatory Affa 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024
Joseph F Flanagan officer: EVP, Quality & Regulatory Affa 10000 WEHRLE DRIVE, CLARENCE NY 14031
Bill R Sanford director 2617 BULRUSH LANE, NAPLES FL 34105
Anthony W Borowicz officer: SVP Strategy,Corp Dev., IR 10000 WEHRLE DRIVE, CLARENCE NY 14031
Sheila Antrum director 5830 GRANITE PARKWAY, SUITE 1150, PLANO TX 75024